Article
Neurodoron® in patients with neurasthenia – A randomized, double-blind, placebo-controlled clinical trial
2022-09-04
Abstract excerpt
1 <h4>Introduction</h4> The term neurasthenia has been introduced in the late 19th century. Stress was indicated as one of the main triggers. Many treatment options are available to reduce the associated symptoms. Complementary and alternative medicine (CAM) is widely used due to its long tradition and positive safety profile. This Phase IV placebo-controlled clinical trial was designed to demonstrate efficacy and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 13d7a330-9107-5269-8e7e-fd432ed3f533
- DOI
- 10.1101/2022.09.02.22279531
